Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCR4-NOT transcription complex subunit 10 (CNOT10) is a protein component of the evolutionarily conserved CCR4-NOT complex, one of the major cellular mRNA deadenylases essential for constitutive mRNA turnover and regulated mRNA decay pathways[3][5]. CNOT10 is a tetratricopeptide repeat (TPR) protein involved primarily in the assembly and structural organization of the N-terminal module of the CCR4-NOT complex, together with CNOT1 and CNOT11[2][3][4]. This module serves as a platform for protein-protein interactions but does not act as a classical therapeutic target such as a receptor, enzyme, or transporter[3][4]. CNOT10 participates in processes including negative regulation of translation and gene expression, but has no known direct roles as a drug target or biomarker[5]. Its depletion or mutation affects the stability of the CCR4-NOT complex and influences specific transcript levels, with limited disease associations reported, notably Mayer-Rokitansky-Kuster-Hauser Syndrome Type 1[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CCR4-NOT transcription complex subunit 10 (CNOT10).